Literature DB >> 32962614

Nanomedicine and Early Cancer Diagnosis: Molecular Imaging using Fluorescence Nanoparticles.

Ke-Tao Jin1, Jia-Yu Yao2,3, Xiao-Jiang Ying4, Yan Lin5, Yun-Fang Chen6.   

Abstract

Incorporating nanotechnology into fluorescent imaging and magnetic resonance imaging (MRI) has shown promising potential for accurate diagnosis of cancer at an earlier stage than the conventional imaging modalities. Molecular imaging (MI) aims to quantitatively characterize, visualize, and measure the biological processes or living cells at molecular and genetic levels. MI modalities have been exploited in different applications including noninvasive determination and visualization of diseased tissues, cell trafficking visualization, early detection, treatment response monitoring, and in vivo visualization of living cells. High-affinity molecular probe and imaging modality to detect the probe are the two main requirements of MI. Recent advances in nanotechnology and allied modalities have facilitated the use of nanoparticles (NPs) as MI probes. Within the extensive group of NPs, fluorescent NPs play a prominent role in optical molecular imaging. The fluorescent NPs used in molecular and cellular imaging can be categorized into three main groups including quantum dots (QDs), upconversion, and dyedoped NPs. Fluorescent NPs have great potential in targeted theranostics including cancer imaging, immunoassay- based cells, proteins and bacteria detections, imaging-guided surgery, and therapy. Fluorescent NPs have shown promising potentials for drug and gene delivery, detection of the chromosomal abnormalities, labeling of DNA, and visualizing DNA replication dynamics. Multifunctional NPs have been successfully used in a single theranostic modality integrating diagnosis and therapy. The unique characteristics of multifunctional NPs make them potential theranostic agents that can be utilized concurrently for diagnosis and therapy. This review provides the state of the art of the applications of nanotechnologies in early cancer diagnosis focusing on fluorescent NPs, their synthesis methods, and perspectives in clinical theranostics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; Early diagnosis; Fluorescent nanoparticles; Molecular imaging; Nanotechnology; Theranostics

Mesh:

Substances:

Year:  2020        PMID: 32962614     DOI: 10.2174/1568026620666200922112640

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  3 in total

Review 1.  The Advances and Biomedical Applications of Imageable Nanomaterials.

Authors:  Xiaohong Xiang; Doudou Shi; Jianbo Gao
Journal:  Front Bioeng Biotechnol       Date:  2022-07-05

Review 2.  Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections.

Authors:  Yuye Wu; Dheerendranath Battalapalli; Mohammed J Hakeem; Venkatarao Selamneni; Pengfei Zhang; Mohamed S Draz; Zhi Ruan
Journal:  J Nanobiotechnology       Date:  2021-12-04       Impact factor: 10.435

3.  Stealth Luminescent Organic Nanoparticles Made from Quadrupolar Dyes for Two-Photon Bioimaging: Effect of End-Groups and Core.

Authors:  Morgane Rosendale; Jonathan Daniel; Frédéric Castet; Paolo Pagano; Jean-Baptiste Verlhac; Mireille Blanchard-Desce
Journal:  Molecules       Date:  2022-03-29       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.